Sign in
4

Changes in Ownership

Whitehawk Therapeutics, Inc. Filed Acc 0001415889-24-006411

Options or other derivatives

  • CHIEF FINANCIAL OFFICER acquired 220,263 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Giacobello Scott M. CHIEF FINANCIAL OFFICER 2024-03-01 Grant or award · Stock Option (right to buy) +138,263 138,263 D
Giacobello Scott M. CHIEF FINANCIAL OFFICER 2024-03-01 Grant or award · Stock Option (right to buy) +55,000 55,000 D
Giacobello Scott M. CHIEF FINANCIAL OFFICER 2024-03-01 Grant or award · Restricted Stock Units +27,000 27,000 D
Loading xslF345X05/form4-03052024_120310.xml…